Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 4 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2006. / Härtill 4 uppsatser.

published_or_final_version / abstract / Anatomy / Master / Master of Philosophy

published_or_final_version / abstract / Anatomy / Doctoral / Doctor of Philosophy

Ip Lai Fong. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (leaves 81-92). / Abstracts in English and Chinese. / Table of Contents --- p.1 / Abbreviations --- p.4 / Chapter Chapter 1 --- Introduction and Background --- p.5 / Chapter 1.1 --- Endothelin system --- p.5 / Chapter 1.1.1 --- Endothelins --- p.5 / Chapter 1.1.2 --- Endothelin converting enzyme (ECE) isoforms --- p.12 / Chapter 1.1.3 --- Endothelin receptors --- p.24 / Chapter 1.2 --- Signal-transduction mechanisms in ET system --- p.27 / Chapter 1.3 --- The aim of the present thesis --- p.31 / Chapter Chapter 2 --- Materials and Methods --- p.32 / Chapter 2.1 --- Primer Design --- p.32 / Chapter 2.2 --- Total RNA Isolation --- p.33 / Chapter 2.3 --- Reverse transcriptase polymerase chain reaction (RT-PCR) --- p.34 / Chapter 2.3.1 --- First Strand cDNA Synthesis --- p.34 / Chapter 2.3.2 --- PCR reaction --- p.34 / Chapter 2.4 --- Agarose gel electrophoresis --- p.35 / Chapter 2.5 --- Ligation of PCR inserts to cloning vector by TA cloning method --- p.35 / Chapter 2.6 --- Competent cell preparation --- p.36 / Chapter 2.7 --- Transformation and Screening --- p.37 / Chapter 2.8 --- Plasmid DNA Extraction --- p.38 / Chapter 2.9 --- DNA sequencing --- p.38 / Chapter 2.10 --- DIG RNA Labeling --- p.38 / Chapter 2.10.1 --- Plasmid Linearization --- p.38 / Chapter 2.10.2 --- Transcription --- p.39 / Chapter 2.10.3 --- Probe purification --- p.39 / Chapter 2.11 --- In situ hybridizaion --- p.40 / Chapter 2.11.1 --- Tissue preparation and slide mounting --- p.40 / Chapter 2.11.2 --- Non-radioactive in situ hybridization --- p.41 / Chapter 2.12 --- Whole Mount non-radioactive in situ hybridization --- p.42 / Chapter 2.12.1 --- Dissection and fixation --- p.42 / Chapter 2.12.2 --- Hybridization --- p.43 / Chapter 2.12.3 --- Antibody incubation --- p.43 / Chapter 2.12.4 --- Histochemistry --- p.44 / Chapter Chapter 3 --- Results --- p.46 / Chapter 3.1 --- The molecular cloning of ECE-2 from rat brain --- p.46 / Chapter 3.2 --- Sequence characteristics of rat ECE-2 --- p.52 / Chapter 3.3 --- Comparison of rat ECE-2 with bovine and human ECE-2 and with the rat ECE-1 --- p.53 / Chapter 3.4 --- Tissue distribution of ECE-2 in rat and localization in C6 glial cells by RT-PCR --- p.60 / Chapter 3.5 --- ECE-2 in rat embryos at different gestation stages by RT-PCR --- p.60 / Chapter 3.6 --- ECE-2 distribution in C6 glioma cells --- p.63 / Chapter 3.7 --- ECE-2 distribution in rat embryo E15.5 --- p.63 / Chapter 3.8 --- ECE-2 distribution in rat brain sections --- p.63 / Chapter Chapter 4 --- p.74 / Discussion --- p.74 / References --- p.81

Thesis (Ph. D.)--University of Washington, 2000. / Vita. Includes bibliographical references (leaves 108-119).

Thesis (Ph.D.)--Virginia Commonwealth University, 2009. / Prepared for: Dept. of Physiology. Title from resource description page. Includes bibliographical references.

In order to understand the possible mechanisms in the glaucoma-related retinopathy, the role of the vasoconstrictor, endothelin-1 (ET-1), receptor for advanced glycation end-products (RAGE) as well as its ligand, Aβ in the degeneration of retinal ganglion cells (RGCs) were studied in experimental models. In addition, the relationship of ET-1, RAGE and Aβ for the RGC protective mechanism of Lycium Barbarum (LB) was also investigated. In the first part, ET-1 together with its receptors, ETA and ETB, were studied to understand their possible roles in chronic ocular hypertension (COH). The neuronal protective mechanism of LB was also determined by using a well established COH rat model. In normal rats, ET-1 and its receptors, ETA and ETB, were distributed in the retina, vasculature and optic nerve. Interestingly, ET-1 expression was up-regulated after COH. LB could decrease the expression of ET-1 and regulate its receptors (up-regulation of ETB and down-regulation of ETA in vasculature; up-regulation of ETA and down-regulation of ETB in RGCs) under the condition of COH. These data suggested that the RGC protective mechanism of LB might be related to its ability to regulate the biological effects of ET-1. To investigate the pathogenic effect of ET-1 in glaucoma, in the second part, we used transgenic mice with over-expression of ET-1 on endothelial cells (TET-1 mice). We found that beginning at 10-12 months, TET-1 mice showed a progressive retinal degeneration (loss of RGCs associated with neurons in the inner nuclear layer and outer nuclear layer of the retina) without elevation of the intraocular pressure (IOP). The data demonstrated that TET-1 mice may serve as a potential model to investigate the role of endothelial ET-1 in the pathogenesis of normal tension glaucoma and other degenerative retinopathy. To investigate whether LB plays a role on neuronal protection other than in COH, in the third part, we used an acute ocular hypertension (AOH)-induced ischemia mouse model. We found that LB could rescue RGCs under AOH insult, associating with blood vessel protection (decreasing the damage of blood-retinal-barriers and rescuing the survival of endothelial cells and pericytes) and inhibiting retinal gliosis. We also found the protective mechanism of LB was closely correlated with down-regulation of the expression of RAGE, ET-1, APP (amyloid precursor protein), AGE (advanced glycation end-product) as well as Aβ; therefore to reduce the damage effects of these RAGE-mediated reactions to the retinal neurons, blood vessels and glial cells involved in the ischemic insult. Taken together, the present study demonstrated that TET-1 mice may be a potential model for investigating the role of ET-1 in degenerative retinopathies, such as normal tension glaucoma. We also showed the neuronal protective mechanism of LB in vivo was associated with inhibiting the biological effect of ET-1 and down-regulating the damage signaling pathways mediated by the activation of RAGE and its ligands (AGE and Aβ). These results provided further understandings in the mechanism of the glaucoma-related retinopathy. In addition, LB could be a neuroprotective agent to the retina following both chronic and acute injuries. / published_or_final_version / Anatomy / Doctoral / Doctor of Philosophy

published_or_final_version / Medical Sciences / Master / Master of Medical Sciences

Diabetes mellitus is a chronic syndrome affecting carbohydrate, protein, and fat metabolism. It is characterized primarily by relative or absolute insufficiency of insulin secretion (type I diabetes or IDDM) or concomitant insensitivity / resistance to the metabolic action of insulin on target tissues (Type II diabetes or NIDDM), both resulting in hyperglycaemia. Diabetes mellitus is known to induce microvascular changes and alterations to neuronal functions. The neurovascular system comprising of unmyelinated primary afferent sensory neurones and the microvasculature innervated by these nerves play a major role in modulating inflammatory and tissue repair processes. Sensory nerve terminals respond to injury via the release of sensory neuropeptides which mediate inflammation and tissue repair. These processes are known to be altered in diabetes. This thesis is concerned with the role of diabetes in modulating microvascular blood flow directly and indirectly via modulating sensory nerve activity and the effect of these changes on repair processes in skin of 4 weeks streptozotocin (STZ)-induced diabetic rats. The following hypotheses were examined: 1. That factors implicated in long-term diabetic vascular damage play a role in altering skin microvascular function in early diabetes. 2. That preventing the deleterious effects of these factors could improve skin microvascular blood flow and skin repair processes in early diabetes. (For complete abstract open document)